Volume 12, Issue 7 (8-2014)
IJRM 2014, 12(7): 507-0 |
Back to browse issues page
1- Department of Medical Parasitology and Mycology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran , arbabi4.mohsen@yahoo.com
2- Department of Medical Parasitology and Mycology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran
2- Department of Medical Parasitology and Mycology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran
Abstract: (5842 Views)
Background: Trichomonas vaginalis infection is one of the most common sexually transmitted diseases in humans. T.vaginalis is a parasitic protozoan with a predilection for human urogenital tract and causative agent for vaginitis, cervicitis and urethritis in females. T.vaginalis infection is associated with risk of Human Immunodeficiency Virus infectivity and pregnancy complication.
Objective: In this study, the prevalence of T.vaginalis in individuals who referred to public health units in Kashan city, Iran was investigated.
Materials and Methods: This study was conducted on 970 women and 235 men who referred to 5 government health centers in Kashan, Iran during October 2012 to August 2013. Demographic information was collected as per the study protocol. Vaginal discharges and urine samples were obtained and examined by Trypticase-Yeast Extract Maltose (TYM) culture medium and wet-mount methods. The prevalence of T. vaginalis was determined using culture based method and wet-mount examinations.
Results: The overall prevalence of trichomonal infection was 2% (95% CI, 2±0.08). The age of infected individual was 33.7±9.4 years. All of those infected, were married housewives and 58.3% of them had primary school education. No statistical correlation was observed between clinical manifestations and parasitological results (p=0.8).
Conclusion: This study showed a relatively low prevalence of T.vaginalis infection in the study population. Since the clinical signs of trichomoniasis are the same of other Sexually Transmitted Diseases (STDs), confirmatory laboratory tests are necessary. Due to adverse outcomes of disease, there is a great need for public education regarding implementation of personal hygienic measures and prevention of inappropriate sexual contacts.
Objective: In this study, the prevalence of T.vaginalis in individuals who referred to public health units in Kashan city, Iran was investigated.
Materials and Methods: This study was conducted on 970 women and 235 men who referred to 5 government health centers in Kashan, Iran during October 2012 to August 2013. Demographic information was collected as per the study protocol. Vaginal discharges and urine samples were obtained and examined by Trypticase-Yeast Extract Maltose (TYM) culture medium and wet-mount methods. The prevalence of T. vaginalis was determined using culture based method and wet-mount examinations.
Results: The overall prevalence of trichomonal infection was 2% (95% CI, 2±0.08). The age of infected individual was 33.7±9.4 years. All of those infected, were married housewives and 58.3% of them had primary school education. No statistical correlation was observed between clinical manifestations and parasitological results (p=0.8).
Conclusion: This study showed a relatively low prevalence of T.vaginalis infection in the study population. Since the clinical signs of trichomoniasis are the same of other Sexually Transmitted Diseases (STDs), confirmatory laboratory tests are necessary. Due to adverse outcomes of disease, there is a great need for public education regarding implementation of personal hygienic measures and prevention of inappropriate sexual contacts.
Type of Study: Original Article |
References
1. Midlej V, Benchimol M. Trichomonas vaginalis kills and eats-evidence for phagocytic activity as a cytopathic effect. Parasitology 2010; 137: 65-76. [DOI:10.1017/S0031182009991041]
2. Van der Pol B. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention. Clin Infect Dis 2007; 44: 23-25. [DOI:10.1086/509934]
3. Vos T, Flaxaman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 15: 2163-2196. [DOI:10.1016/S0140-6736(12)61729-2]
4. Van Der Pol B, Kwok C, Pierre-Louis B, Rinaldi A, A.Salata R, Chen PL, et al. Trichomonas vaginalis infection and HIV Acquisition in African women. J Infect Dis 2008; 197: 548-554. [DOI:10.1086/526496]
5. Pustan L, Ailiesei O, Dunca S. Trichomonas vaginalis a risk factor for cervical cancer. Gen Mol Biol 2010; 11: 107-112.
6. Harp DF, Chowdhury I. Trichomoniasis: Evaluation to execution. Eu J Obstet Gynecol Reprod Biol 2011; 157: 3-9. [DOI:10.1016/j.ejogrb.2011.02.024]
7. N Poole D, McClelland RS. Global epidemiology of Trichomonas vaginalis. Sex Transm Infect 2013; 89: 418-422. [DOI:10.1136/sextrans-2013-051075]
8. Radonjic IV, Dzamic AM, Mitrovic SM, Arsic Arsenijevic VS, Popadic DM, Kranjcic Zec IF. Diagnosis of Trichomonas vaginalis infection: The sensitivities and specificities of microscopy, culture and PCR assay. Eur J Obstet Gynecol Reprod Biol 2006; 126: 116-120. [DOI:10.1016/j.ejogrb.2005.07.033]
9. Rezaeian M, Vatanshenassan M, Rezaie S, Mohebali M, Niromand N, Niyyati M, et al. Prevalence of Trichomonas vaginalis Using Parasitological Methods in Tehran. Iran J Parasitol 2009; 4: 43-47.
10. Matini M, Rezaie S, Mohebali M, Maghsood AH, Rabiee S, Fallah M, et al. Prevalence of Trichomonas vaginalis Infection in Hamadan City, Western Iran. Iran J Parasitol 2012; 7: 67-72.
11. Kassem HH, Majoud OA. Trichomoniasis among women with vaginal discharge in Benghazi city, Libya. J Egypt Soc Parasitol 2006; 36: 1007- 1016.
12. Mahafzah AM, Al-Ramahi MQ, Asa'd AM, El-Khateeb MS. Prevalence of sexually transmitted infections among sexually active Jordanian females. Sex Transm Dis 2008; 35: 607-610. [DOI:10.1097/OLQ.0b013e3181676bbd]
13. Madani TA. Sexually transmitted infections in Saudi Arabia. BMC Infect Dis 2006; 6: 3. [DOI:10.1186/1471-2334-6-3]
14. Mazloumi Gavgani A-S, Namazi A, Ghazanchaei A, Alizadeh S, Sehhati F, Rostamzadeh S, et al. Prevalence and risk factors of trichomoniasis among women in Tabriz. Iran J Clin Infect Dis 2008; 3: 67-71.
15. Rezaeian M, Vatanshenassan M, Rezaie S, Mohebal M, Niromand N, Niyyati M, et al. Prevalence of Trichomonas vaginalis Using Parasitological Methods in Tehran. Iran J Parasitol 2009; 4: 43-47.
16. Fattahi Bafghi A, Aflatoonian A, Barzegar K, Ghafourzadeh M, Nabipour S. Frequency distribution of trichomoniasis in pregnant women referred to health centers of Ardakan, Meibod and Yazd, Iran. Jundishapur J Microbiol 2009; 2: 132-139.
17. Sena AC, Miller WC, Hobbs MM, Schwebke JR, Leone PA, Swygard H, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis 2007; 44: 13-22. [DOI:10.1086/511144]
18. Figueroa-Angulo EE, Rendon-Gandarilla FJ, Puente-Rivera J, Calla-Choque GS, Cárdenas-Guerra RE, Ortega-López J, et al. The effects of environmental factors on the virulence of Trichomonas vaginalis. Microb Infect 2012; 14: 1411-1427. [DOI:10.1016/j.micinf.2012.09.004]
19. Vatanshenassan M, Rezaie S, Mohebali M, Niromand N, Kazemi B, Babaei Z, et al. Trichomonas vaginalis: investigation of a novel diagnostic method in urine samples using cysteine proteinase 4 gene and PCR technique. Exp Parasitol 2010; 126: 187-190. [DOI:10.1016/j.exppara.2010.04.021]
20. Van Der Pol B, Kraft CS, Williams JA. Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens. J Clin Microbiol 2006; 44: 366-373. [DOI:10.1128/JCM.44.2.366-373.2006]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |